Sanofi India

₹3,302As of Sun 8 Nov 2026, 12:00 UTC

NSE:SANOFIHealthcare

Country India

PE (Fwd) 24.54

TSR 10Y CAGR 7.49%

Div yield 3.73%

ROE —

Drug Manufacturers (General)

Beta (5Y) 0.11

PE TTM 23.28

TSR TTM (27.29%)

Mkt cap ₹77.45B

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹3,525

6.75%

(53.74%)

Price above Reference Value

FY22

FY23

FY24

FY25

Earnings per share₹

269.47

261.78

179.54

141.85

(34.29%)

(2.85%)

(31.41%)

(20.99%)

Revenue₹B

27.70

19.96

20.13

18.37

(6.31%)

(27.94%)

0.86%

(8.73%)

TTM

FYE 31 Dec INR

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

18.37

Revenue₹B

—

29.57

27.70

19.96

20.13

18.37

17.99

(11.21%)

(8.73)

Revenue growth%

—

(6.31)

(27.94)

0.86

(8.73)

(2.08)

(7.52)

—

50.46

Gross margin%

—

55.24

56.49

51.65

50.62

50.46

50.50

51.65

24.73

Operating margin%

—

23.54

24.04

22.72

22.55

24.73

24.74

23.54

17.78

Net margin%

—

31.94

22.40

30.20

20.54

17.78

17.48

22.40

23.28

P/E ratio (avg)x

—

19.69

23.93

25.85

41.03

37.13

24.18

25.85

16.74

EV/EBITx

—

26.72

22.30

34.36

37.37

26.70

17.08

26.72

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

141.85

EPS₹

—

410.06

269.47

261.78

179.54

141.85

136.57

(23.31%)

—

(20.99)

EPS growth%

—

(34.29)

(2.85)

(31.41)

(20.99)

(3.72)

(26.20)

—

Bookvalue per sh₹

—

FCF per share₹

—

123.00

Dividend per sh₹

—

181.00

194.00

167.00

117.00

123.00

122.47

(9.21%)

—

3.73

Div yield (avg)%

—

2.24

3.01

2.47

1.59

2.34

3.71

2.34

86.71

Payout ratio%

—

44.14

71.99

63.79

65.17

86.71

89.68

65.17

23.03

Shares (diluted)M

—

23.03

◌23.03

—

Buyback yield%

—

◌—

—

D/E ratiox

—

76.04

Enterprise value₹B

—

185.9

148.5

155.8

169.6

121.3

76.04

(10.13%)

—

LT debt₹M

—

Peers (US$805.5M)

Cap (US$)

Sanofi Consumer…

830.4M

27.88x

Senores Pharmaceutical…

566.5M

39.54x

SMS Pharmaceuticals…

498.1M

39.99x

Zhejiang Int'l Group…

827.2M

11.31x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

267.2

302.6

Own earn%

—

Sh yield%

3.73

2.40

Owners

Insiders/Inst%

—

24.65

Short interest%

—

SBC / revenue%

0.09

Record

10Y

Profitable years

5/5

Revenue growth years

1/4

EPS growth years

0/4

Dividend streakyrs

Op margin range%

23–25

$1 testx

—

Incr. ROIC%

—

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹18.37B

(11.21%)

1.00×

Cost of revenue

₹9.102B

(8.93%)

1.11×

Operating expenses

₹4.729B

(15.72%)

0.81×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m